Author

Masayoshi Nogami

Institution: Fuji Pharma Co., Ltd. (Japan)

Observed institution: Fuji Pharma Co., Ltd. (Japan)

ORCID: 0009-0003-7811-8447

Observed ORCID: 0009-0003-7811-8447

OpenAlex ID: A5109791033

Impact of Estetrol Combined with Drospirenone on Blood Coagulation and Fibrinolysis in Patients with Endometriosis: A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study

2024 · Takao Kobayashi, Masashi Hirayama, et al. · Clinical and Applied Thrombosis/Hemostasis · 23

Efficacy and safety of the combination of estetrol 15 mg/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized study

2024 · Tasuku Harada, Takao Kobayashi, et al. · Fertility and Sterility · 19

Efficacy and safety of estetrol (15 mg)/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study

2024 · Yutaka Osuga, Takao Kobayashi, et al. · Fertility and Sterility · 16

Impact of estetrol and drospirenone combination therapy on alleviation of the pelvic pain of endometriosis: a randomized control trial

2025 · Tasuku Harada, Masayoshi Nogami, et al. · F&S Reports · 4

Post Hoc Analysis of a Previous Study of Estetrol 15 mg/Drospirenone 3 mg Combination for Dysmenorrhea and Uterine Bleeding in Adenomyosis Patients

2026 · Tasuku Harada, Takao Kobayashi, et al. · Reproductive Medicine and Biology · 2

Works count: 5

Citation count: 64

H-index: 4

I10-index: 3